Emerging respiratory infections threatening public health in the Asia-Pacific region: A position paper of the Asian Pacific Society of Respirology

Respirology

Volumn 24, Issue 6, 2019, Pages 590-597

  Park, Sunghoon ^a   Park, Ji Young ^a   Song, Yuanlin ^b   How, Soon Hin ^c   Jung, Ki Suck ^a  

^a Hallym University   (South Korea)

^b FUDAN UNIVERSITY   (China)

^c INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

avian influenza; pandemic; respiratory infection; virus

Indexed keywords

INFLUENZA VACCINE; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE;

ASIA; AVIAN INFLUENZA (H5N1); AVIAN INFLUENZA VIRUS; AVIATION; CLUSTER ANALYSIS; DISEASE BURDEN; DISEASE CONTROL; DISEASE SURVEILLANCE; ECONOMIC ASPECT; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; GLOBAL HEALTH; HUMAN; INFLUENZA A; INFLUENZA A (H7N9); INTERMETHOD COMPARISON; LIFE THREAT; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; ONE HEALTH; PACIFIC ISLANDS; PRIORITY JOURNAL; PUBLIC HEALTH; RESPIRATORY TRACT INFECTION; REVIEW; SARS-RELATED CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; CONTACT EXAMINATION; INFECTION CONTROL; MICROBIOLOGY; ORGANIZATION AND MANAGEMENT; PROCEDURES; VIROLOGY;

ASIA; CONTACT TRACING; EPIDEMICS; GLOBAL HEALTH; HUMANS; INFECTION CONTROL; PUBLIC HEALTH; RESPIRATORY TRACT INFECTIONS;

EID: 85064566343     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.13558     Document Type: Review

References (77)

1. Kotsimbos T, Waterer G, Jenkins C, Kelly PM, Cheng A, Hancox RJ, Holmes M, Wood-Baker R, Bowler S, Irving L et al.; Thoracic Society of Australia and New Zealand H1N1 Influenza 09 Task Force. Influenza A/H1N1_09: Australia and New Zealand's winter of discontent. Am. J. Respir. Crit. Care Med. 2010; 181: 300–6.
2. WHO. Weekly epidemiological record. [Accessed 5 Nov 2017.] Available from URL: http://apps.who.int/iris/bitstream/10665/252537/1/WER9151_52.pdf?ua=1
3. Yoo BK. How to improve influenza vaccination rates in the U.S. J. Prev. Med. Public Health 2011; 44: 141–8.
4. Elbahesh H, Saletti G, Gerlach T, Rimmelzwaan GF. Broadly protective influenza vaccines: design and production platforms. Curr. Opin. Virol. 2018; 26: 1–9.
5. Hui DSC, Lee N, Chan PKS. A clinical approach to the threat of emerging influenza viruses in the Asia-Pacific region. Respirology 2017; 22: 1300–12.
6. CDC. Asian lineage avian influenza A(H7N9) virus. [Accessed 5 Nov 2017.] Available from URL: https://www.cdc.gov/flu/avianflu/h7n9-virus.htm
7. WHO. Emergencies preparedness, response. Human infection with avian influenza A(H7N9) virus – China. [Accessed 5 Nov 2017.] Available from URL: http://www.who.int/csr/don/26-october-2017-ah7n9-china/en/
8. Lai S, Qin Y, Cowling BJ, Ren X, Wardrop NA, Gilbert M, Tsang TK, Wu P, Feng L, Jiang H et al. Global epidemiology of avian influenza A H5N1 virus infection in humans, 1997-2015: a systematic review of individual case data. Lancet Infect. Dis. 2016; 16: e108–18.
9. Hui DS. Review of clinical symptoms and spectrum in humans with influenza A/H5N1 infection. Respirology 2008; 13(Suppl. 1): S10–3.
10. Animal Production and Health. H7N9 situation update. [Accessed 20 Aug 2018.] Available from URL: http://www.fao.org/ag/againfo/programmes/en/empres/h7n9/situation_update.html
11. Li Q, Zhou L, Zhou M, Chen Z, Li F, Wu H, Xiang N, Chen E, Tang F, Wang D et al. Epidemiology of human infections with avian influenza A(H7N9) virus in China. N. Engl. J. Med. 2014; 370: 520–32.
12. Tanner WD, Toth DJ, Gundlapalli AV. The pandemic potential of avian influenza A(H7N9) virus: a review. Epidemiol. Infect. 2015; 143: 3359–74.
13. Zhang R, Chen T, Ou X, Liu R, Yang Y, Ye W, Chen J, Yao D, Sun B, Zhang X et al. Clinical, epidemiological and virological characteristics of the first detected human case of avian influenza A(H5N6) virus. Infect. Genet. Evol. 2016; 40: 236–42.
14. WHO. Avian influenza weekly update number 584. [Accessed 15 Nov 2017.] Available from URL: http://www.wpro.who.int/emerging_diseases/ai_weekly_584_wpro_20170512.pdf
15. Yang ZF, Mok CK, Peiris JS, Zhong NS. Human infection with a novel avian influenza A(H5N6) virus. N. Engl. J. Med. 2015; 373: 487–9.
16. WHO. Influenza at the human-animal interface. [Accesssed 17 Nov 2017.] Available from URL: http://www.who.int/influenza/human_animal_interface/Influenza_Summary_IRA_HA_interface:25_02_2016.pdf
17. Cheng VC, Chan JF, Wen X, Wu WL, Que TL, Chen H, Chan KH, Yuen KY. Infection of immunocompromised patients by avian H9N2 influenza A virus. J. Infect. 2011; 62: 394–9.
18. Bui CM, Chughtai AA, Adam DC, MacIntyre CR. An overview of the epidemiology and emergence of influenza A infection in humans over time. Arch. Public Health 2017; 75: 15–21.
19. Liu M, Li X, Yuan H, Zhou J, Wu J, Bo H, Xia W, Xiong Y, Yang L, Gao R et al. Genetic diversity of avian influenza A (H10N8) virus in live poultry markets and its association with human infections in China. Sci. Rep. 2015; 5: 7632.
20. Xu Y, Cao H, Liu H, Sun H, Martin B, Zhao Y, Wang Q, Deng G, Xue J, Zong Y et al. Identification of the source of A (H10N8) virus causing human infection. Infect. Genet. Evol. 2015; 30: 159–63.
21. CDC. Morbidity and Mortality Weekly Report. [Accessed 20 November 2017.] Available from URL: https://www.cdc.gov/mmwr/volumes/65/wr/mm6542a1.htm
22. CDC. Influenza (flu). Case count: detected U.S. human infections with H3N2v by state since August 2011. [Accessed 20 Nov 2017.] Available from URL: https://www.cdc.gov/flu/swineflu/h3n2v-case-count.htm
23. Jhung MA, Epperson S, Biggerstaff M, Allen D, Balish A, Barnes N, Beaudoin A, Berman L, Bidol S, Blanton L et al. Outbreak of variant influenza A(H3N2) virus in the United States. Clin. Infect. Dis. 2013; 57: 1703–12.
24. Zhou L, Tan Y, Kang M, Liu F, Ren R, Wang Y, Chen T, Yang Y, Li C, Wu J et al. Preliminary epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus, China, 2017. Emerg. Infect. Dis. 2017; 23: 1355–9.
25. World Organization for Animal Health. OIE expert mission finds live bird markets play a key role in poultry and human infections with influenza A(H7N9). [Accessed 5 Nov 2017.] Available from URL: http://www.oie.int/en/for-the-media/press-releases/detail/article/oie-expert-mission-finds-live-bird-markets-play-a-key-role-in-poultry-and-human-infections-with-infl/
26. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, Cheung PT, To WK, Ho ET, Sung R et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351: 467–71.
27. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, de Jong MD, Naghdaliyev A, Peiris JS, Shindo N, Soeroso S et al.; Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A(H5N1) Virus. Update on avian influenza A (H5N1) virus infection in humans. N. Engl. J. Med. 2008; 358: 261–73.
28. WHO. Emergencies preparedness, response. Avian influenza – situation in Viet Nam – update. [Accessed 5 Dec 2017.] Available from URL: http://www.who.int/csr/don/2012_03_12/en/
29. Wang H, Feng Z, Shu Y, Yu H, Zhou L, Zu R, Huai Y, Dong J, Bao C, Wen L et al. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet 2008; 371: 1427–34.
30. Wang TT, Parides MK, Palese P. Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science 2012; 335: 1463.
31. Wei SH, Yang JR, Wu HS, Chang MC, Lin JS, Lin CY, Liu YL, Lo YC, Yang CH, Chuang JH et al. Human infection with avian influenza A H6N1 virus: an epidemiological analysis. Lancet Respir. Med. 2013; 1: 771–8.
32. WHO. Zoonotic influenza viruses: antigenic and genetic charateristics and development of candidate vaccine viruses for pandemic preparedness. [Accessed 13 Nov 2017.] Available from URL: http://apps.who.int/iris/bitstream/10665/259277/1/WER9242-633-647.pdf?ua=1
33. Khan SU, Anderson BD, Heil GL, Liang S, Gray GC. A systematic review and meta-analysis of the seroprevalence of influenza A(H9N2) infection among humans. J. Infect. Dis. 2015; 212: 562–9.
34. Gu M, Xu L, Wang X, Liu X. Current situation of H9N2 subtype avian influenza in China. Vet. Res. 2017; 48: 49–58.
35. Liu D, Shi W, Shi Y, Wang D, Xiao H, Li W, Bi Y, Wu Y, Li X, Yan J et al. Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet 2013; 381: 1926–32.
36. Liu D, Shi W, Shi Y, Wang D, Xiao H, Li W, Bi Y, Wu Y, Li X, Yan J et al. Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study. Lancet 2014; 383: 714–21.
37. WHO. WHO guidelines for the global surveillance of severe acute respiratory syndrome (SARS). Updated recommendations, October 2004. [Accessed 20 Nov 2017.] Available from URL: http://www.who.int/csr/resources/publications/WHO_CDS_CSR_ARO_2004_1/en/
38. Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet 2015; 386: 995–1007.
39. Choi WS, Kang CI, Kim Y, Choi JP, Joh JS, Shin HS, Kim G, Peck KR, Chung DR, Kim HO et al. Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea. Infect. Chemother. 2016; 48: 118–26.
40. WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). [Accessed 26 Nov 2017.] Available from URL: http://www.who.int/emergencies/mers-cov/en/
41. WHO. WHO MERS-CoV global summary and assessment of risk. [Accessed 20 Nov 2017.] Available from URL: http://www.who.int/emergencies/mers-cov/risk-assessment-july-2017.pdf?ua=1
42. Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology 2018; 23: 130–7.
43. WHO. Emergencies preparedness, reponse. China's latest SARS outbreak has been contained, but biosafety concerns remain – Update 7. [Accessed 26 Nov 2017.] Available from URL: http://www.who.int/csr/don/2004_05_18a/en/
44. Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology 2003; 8(Suppl.): S9–14.
45. Kang CK, Song KH, Choe PG, Park WB, Bang JH, Kim ES, Park SW, Kim HB, Kim NJ, Cho SI et al. Clinical and epidemiologic characteristics of spreaders of Middle East respiratory syndrome coronavirus during the 2015 outbreak in Korea. J. Korean Med. Sci. 2017; 32: 744–9.
46. Hui DS, Azhar EI, Kim YJ, Memish ZA, Oh MD, Zumla A. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect. Dis. 2018; 18: e217–27.
47. WHO. Emergencies preparedness, response. Middle East respiratory syndrome coronavirus (MERS-CoV) – Oman. [Accessed 26 Nov 2017.] Available from URL: http://www.who.int/csr/don/10-november-2017-mers-oman/en/
48. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, Flemban H, Al-Nassir WN, Balkhy HH, Al-Hakeem RF et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect. Dis. 2013; 13: 752–61.
49. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, Ahuja A, Yung MY, Leung CB, To KF et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 2003; 348: 1986–94.
50. Chen WQ, Ling WH, Lu CY, Hao YT, Lin ZN, Ling L, Huang J, Li G, Yan GM. Which preventive measures might protect health care workers from SARS? BMC Public Health 2009; 9: 81–8.
51. Christian MD, Poutanen SM, Loutfy MR, Muller MP, Low DE. Severe acute respiratory syndrome. Clin. Infect. Dis. 2004; 38: 1420–7.
52. WHO. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. [Accessed 20 Nov 2017.] Available from URL: http://www.who.int/csr/sars/country/table2004_04_21/en/index.html
53. CDC. Middle East respiratory syndrome (MERS). People who may be at incresaed risk for MERS. [Accessed 10 Mar 2018.] Available from URL: https://www.cdc.gov/coronavirus/mers/risk.html
54. Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J. Infect. Dis. 2017; 15: S28–36.
55. Hsu LY, Apisarnthanarak A, Khan E, Suwantarat N, Ghafur A, Tambyah PA. Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia. Clin. Microbiol. Rev. 2017; 30: 1–22.
56. Du H, Chen L, Tang YW, Kreiswirth BN. Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae. Lancet Infect. Dis. 2016; 16: 287–8.
57. Patel G, Bonomo RA. "Stormy waters ahead": global emergence of carbapenemases. Front. Microbiol. 2013; 4: 48.
58. Dortet L, Poirel L, Nordmann P. Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria. Biomed. Res. Int. 2014; 2014: 249856.
59. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect. Dis. 2016; 16: 161–8.
60. WHO. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. [Accessed 20 Aug 2018.] Available from URL: http://www.who.int/infection-prevention/publications/guidelines-cre/en/
61. European Centre for Disease Prevention and Control. European Antimicrobial Resistance Surveillance Network (EARS-Net). [Accessed 31 Dec 2018.] Available from URL: https://ecdc.europa.eu/en/about-us/partnerships-and-networks/disease-and-laboratory-networks/ears-net
62. WHO. Global antimicrobial resistance surveillance system (GLASS). [Accessed 31 Dec 2018.] Available from URL: https://www.who.int/glass/en/
63. Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther. Adv. Drug Saf. 2014; 5: 229–41.
64. WHO. Global action plan on antimicrobial resistance. [Accessed 31 Dec 2018.] Available from URL: https://www.who.int/antimicrobial-resistance/global-action-plan/en/
65. WHO. Emergencies preparedness, response. Infection prevention and control of epidemic-and pandemic prone acute respiratory infections in health care. [Accessed 10 Mar 2018.] Available from URL: http://www.who.int/csr/bioriskreduction/infection_control/publication/en/
66. Leder K, Newman D. Respiratory infections during air travel. Intern. Med. J. 2005; 35: 50–5.
67. Mangili A, Vindenes T, Gendreau M. Infectious risks of air travel. Microbiol. Spectr. 2015; 3: 1-10.
68. Leitmeyer K. European risk assessment guidance for infectious diseases transmitted on aircraft – the RAGIDA project. Euro. Surveill. 2011; 16: pii: 19845.
69. ECDC. Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA): influenza. [Accessed 20 Aug 2018.] Available from URL: https://ecdc.europa.eu/en/publications-data/risk-assessment-guidelines-infectious-diseases-transmitted-aircraft-ragida
70. CDC. Quarantine and isolation. Protecting travelers' health from airport to community: investigating contagious diseases on flights. [Accessed 20 Aug 2018.] Available from URL: https://www.cdc.gov/quarantine/contact-investigation.html
71. WHO. WHO technical advice for case management of influenza A(H1N1) in air transport. [Accessed 20 Aug 2018.] Available from URL: http://www.who.int/ihr/travel/A(H1N1)_air_transport_guidance.pdf
72. WHO. FAO/OIE/WHO collaboration (tripartite). [Accessed 15 Nov 2017.] Available from URL: http://www.who.int/foodsafety/areas_work/zoonose/concept-note/en/
73. WHO. One Health. [Accessed 15 Nov 2017.] Available from URL: http://www.who.int/features/qa/one-health/en/
74. McCloskey B, Dar O, Zumla A, Heymann DL. Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spread. Lancet Infect. Dis. 2014; 14: 1001–10.
75. Heymann DL, Dar OA. Prevention is better than cure for emerging infectious diseases. BMJ 2014; 348: g1499.
76. Vong S, O'Leary M, Feng Z. Early response to the emergence of influenza A(H7N9) virus in humans in China: the central role of prompt information sharing and public communication. Bull. World Health Organ. 2014; 92: 303–8.
77. McNabb SJ, Shaikh AT, Nuzzo JB, Zumla AI, Heymann DL. Triumphs, trials, and tribulations of the global response to MERS coronavirus. Lancet Respir. Med. 2014; 2: 436–7.